Drug Collections

Insys Litigation Documents


U.S. v. Kapoor, et al., 16-cr-10343, U.S. District Court, District of Massachusetts (Boston)

In 2016, former executives and managers of Insys Therapeutics Inc. (makers of Subsys, a fentanyl-based pain medication), were indicted by a Grand Jury on charges including conspiracy to commit racketeering, mail and wire fraud, and conspiracy to violate the anti-kickback law in relation to a nationwide conspiracy to bribe medical practitioners and defraud insurers.

The resulting federal trial alleged Dr John Kapoor, the founder of Insys Therapeutics, and his co-defendants, had paid doctors to prescribe its potent opioid medication and then lied to insurance companies to ensure that the expensive painkiller would be covered.

This 2019 trial resulted in the conviction of Kapoor, as well as the company’s vice president of managed markets, national director of sales, and two Insys regional sales directors. Kapoor became the first opioid CEO to be sentenced to prison.

Current documents include 45 volumes of transcripts from the trial.

Dates: 2016 and 2019

Related Resources